TherapeuticsMD Annual Revenue, Number of Employees, Growth and Funding
Estimated Revenue & Financials
- TherapeuticsMD's estimated annual revenue is currently $16.1M per year.
- TherapeuticsMD received $85.0M in venture funding in August 2018.
- TherapeuticsMD's estimated revenue per employee is $40,758
- TherapeuticsMD's total funding is $11M.
- TherapeuticsMD has 395 Employees.
- TherapeuticsMD grew their employee count by 32% last year.
- TherapeuticsMD currently has 24 job openings.
|Robert Finizio||Chief Executive Officer, Co-Founder, and Director|
|Mitchell Krassan||Chief Strategy Performance Officer|
|Julia Amadio||Chief Product Officer|
|Christian Bloomgren||VP Sales|
|Marlan Walker||General Counsel and Chief Development Officer|
|Sebastian Mirkin||Chief Medical Officer|
|Brian Bernick||Co-Founder and Director|
|Harpreet Singh||Director, Data Architecture|
|Glynis Tavares||Director, Commercial Compliance|
What Is TherapeuticsMD?
TherapeuticsMD, Inc. is an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their health care issues. We create products to address the unique changes and challenges women experience through every stage of their lives. With momentum fueled by the needs of our customers, we combine entrepreneurial spirit and clinical expertise to develop innovative solutions designed to go beyond what is presently available. This includes a variety of therapies in our pipeline, along with prescription prenatal vitamins under the vitaMedMD® and BocaGreenMD® brands. See our community guidelines: https://www.therapeuticsmd.com/social-media-community-guidelineskeywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Redmond and Gre...||$11.7M||62||19%||N/A|
Shares of TherapeuticsMD (NASDAQ: TXMD) jumped 34% in August, according to data provided by S&P Global Market Intelligence, after the ...
TherapeuticsMD Inc. shares TXMD, +3.61% slid about 6% Tuesday, after the Securities and Exchange Commission charged the company with ...
Russell Angus C., Director, added 10,000 shares of TherapeuticsMD, Inc. (TXMD) to its portfolio at the rate of $2.77 per share valuing $27,700 ...
|2015-02-12||$Undisclosed||Undisclosed||Cowen and Company||Article|
|2018-08-01||$85.0M||Undisclosed||Goldman Sachs & Co. LLC||Article|
TherapeuticsMD Executive Hires
|2013-10-31||Sebastian Mirkin||Chief Medical Officer||Article|
|2013-12-05||Joel S. Krasnow||Chief Scientific Officer/Head Regulatory Department||Article|
|2016-11-04||Dawn Halkuff||Chief Commercial Officer||Article|
TherapeuticsMD New Location/Offices